Related Experiment Video
Updated: Apr 27, 2026
05:56
Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
2.8K
Chemotherapy-induced nausea and vomiting: optimizing prevention and management
1Oncology/BMT clinical pharmacist practitioner, University of North Carolina Hospitals and Clinics, Chapel Hill, NC.
American Health & Drug Benefits
|July 4, 2014
Summary
Chemotherapy-induced nausea and vomiting (CINV) significantly impacts cancer patients. Effective management requires understanding CINV mechanisms and current pharmacologic treatments for optimal patient care.
Area of Science:
- Oncology
- Pharmacology
Background:
- Nausea and vomiting are significant chemotherapy side effects impacting patient quality of life and treatment adherence.
- Despite advancements, chemotherapy-induced nausea and vomiting (CINV) remains a distressing issue for cancer patients.
Purpose of the Study:
- To review the mechanisms of CINV.
- To discuss current pharmacologic strategies for CINV management.
- To present national practice guidelines for CINV treatment.
Main Methods:
- Review of CINV mechanisms.
- Analysis of current pharmacologic therapies.
- Examination of national cancer organization guidelines.
Main Results:
- Optimal CINV management involves understanding mechanisms and current therapies.
- Value-based decision-making and cost considerations are crucial for providers and payers.
- Individualized patient evaluation is necessary for selecting the best antiemetic regimen.
Conclusions:
- Numerous preventive and treatment options exist for CINV.
- Ongoing patient assessment is key to tailoring antiemetic regimens.
- Understanding CINV and its management is vital for improving patient outcomes.
Related Concept Videos
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
919
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
919
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
816
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
816
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
1.1K
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
1.1K
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
1.1K
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
1.1K
01:22Pathophysiology of Vomiting
4.5K
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
4.5K
01:14Prevention of Further Absorption of Poison
1.4K
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.4K